Новости и публикации
Hydrochlorothiazide/Spironolactone: CMDh Scientific Findings and Basis for Changes, Amendments to Product Information and Implementation Schedule — PSUSA / 00001662/202101
Given the available data from the literature on acute respiratory toxicity, including acute respiratory [...]
Changes were made to the list of activities carried out by the National Center for Expertise of Medicines and Medical Devices
By Order No. KP DSM-107 of the Minister of Health of the Republic of [...]
Pharmacovigilance: on the formation of periodic updated safety reports
Currently, the development of analytical databases on the Internet makes it possible to determine [...]
82.8% of infectious disease beds occupied for patients with COVID-19
As of the morning of November 9, 82.8% of infectious disease beds for patients [...]
Gender peculiarities in the development of adverse reactions of medicinal products
Matveev A.V., Krasheninnikov A.E., Egorova E.A., Konyaeva E.I., Bekirova E.Yu.National Scientific Center for [...]
Гендерные особенности развития нежелательных реакций леркарственных
Матвеев А.В., Крашенинников А.Е., Егорова Е.А., Коняева Е.И., Бекирова Э.Ю.Национальный научный центр фармаконадзора, [...]